Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the In-Vitro Toxicology Testing Market Growth in 2025?

The market size for in-vitro toxicology testing has experienced significant growth in the past few years. The market, which is projected to increase from $11.53 billion in 2024 to $12.77 billion in 2025, is expected to see a compound annual growth rate (CAGR) of 10.7%. This notable rise during the historical period can be linked to regulatory requirements, ethical considerations for animal welfare, cost and time efficiency, the international expansion of the pharmaceutical industry, the requirements of drug discovery and development, as well as increased public cognizance of environmental toxins.

What Is the Forecast for the In-Vitro Toxicology Testing Market Size Through 2029?

The market size for in-vitro toxicology testing is forecasted to experience swift expansion in the upcoming years, increasing to $19.18 billion in 2029 with a compound annual growth rate (CAGR) of 10.7%. This predicted growth can be credited to factors such as the emphasis on personalized medicine, the need for predictive toxicology models, the broadening of environmental testing, and challenges in oncology drug development. Other contributing elements include the concentration on endocrine disruptor screening and the transition towards multi-organ chips. During the forecast period, significant trends are expected to include progress in 3d cell culture technologies, the inclusion of high-throughput screening, concentration on organ-on-a-chip technologies, application in chemical safety assessments, the usage of human-derived cell lines, adoption of omics technologies, and educational and training programs.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7987&type=smp

What are the Key Market Players in In-Vitro Toxicology Testing Market and How They’re Evolving?

Major companies operating in the in-vitro toxicology testing market are Thermo Fisher Scientific Inc., Merck KGaA, Laboratory Corporation of America Holdings (LabCorp), Gentronix Limited (a subsidiary of Eurofins Scientific SE), Bio-Rad Laboratories Inc., Eurofins Scientific SE, Charles River Laboratories International Inc., Promega Corporation, Agilent Technologies Inc., Evotec SE, SGS SA, BioIVT LLC, MB Research Laboratories LLC, Creative Biolabs Inc., Creative Bioarray Inc., InSphero AG, PerkinElmer Inc., Cyprotex PLC, MatTek Corporation, Danaher Corporation, Ncardia AG, Sekisui Chemical Co. Ltd., BioReliance Corporation, CellSystems Biotechnologie Vertrieb GmbH, Taconic Biosciences Inc., Biopredic International, MultiCell Technologies Inc., Altasciences Clinical Research Holdings Inc., Molecular Toxicology Inc., Toxys BV, XenoTech LLC, Optivia Biotechnology Inc., Toxikon Corporation

What Are the Primary Growth Drivers in the In-Vitro Toxicology Testing Market?

The surge in health spending is projected to stimulate the progress of the in-vitro toxicology testing market. The financial resources allocated by individuals and the government towards healthcare services such as hospitals, home health facilities, prescribed medications, nursing homes, and personal healthcare are growing globally. This growth is being driven by the escalating prevalence of diseases that require in-vitro toxicology testing. For example, a report by the US-based federal agency, Centers for Medicare & Medicaid Services, in September 2024 revealed that from 2023 to 2032, the average growth rate of national health expenditure (NHE) is anticipated to reach 5.6%, exceeding the average GDP growth rate of 4.3%. Consequently, the proportion of healthcare expenditure to GDP is anticipated to elevate from 17.3% in 2022 to 19.7% in 2032. Therefore, the increase in healthcare expenditure is a major driver of the in-vitro toxicology testing market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7987&type=smp

What Are the Leading Segments in the Global In-Vitro Toxicology Testing Industry?

The in-vitro toxicology testing market covered in this report is segmented –

1) By Product And Service: Consumables, Assays, Equipment, Software, Services

2) By Method: Cellular Assays, Biochemical Assays, In Silico Models, Ex Vivo Models

3) By Technology: Cell Culture Technologies, High-throughput Technologies, Toxicogenomics

4) By Applications: Neurotoxicity, Dermal toxicity, Cytotoxicity, Other Applications

5) By Industry: Pharmaceuticals And Biopharmaceuticals, Cosmetic And Household Products, Food, Chemicals

Subsegments:

1) By Consumables: Reagents, Cell Culture Media, Plates And Vials

2) By Assays: Cell-Based Assays, Biochemical Assays, Genetic Toxicity Assays

3) By Equipment: Automated Systems, Microscopes, Plate Readers

4) By Software: Data Analysis Software, Laboratory Information Management Systems (LIMS), Toxicology Modeling Software

5) By Services: Testing Services, Consultation Services, Regulatory Compliance Services

What Are the Key Market Trends in the In-Vitro Toxicology Testing Industry?

In the in-vitro toxicology market, a significant trend that’s gaining traction is the advancement of novel cell therapy. The main players in the in-vitro toxicology testing arena are dedicated to formulating new funding mechanisms to fortify their market standing. An example of this is from June 2024, when Waypoint Bio, an American Biotechnology firm, revealed $14.5 million of seed funding for innovatory cell treatments for solid tumors, utilizing in-vivo spatial pooled screening technology. This platform melds spatial biology with pooled screening, enabling concurrent analysis of different cell therapy contenders’ interactions within the solid tumor microenvironment. With the capability to assess hundreds of phenotypes at a single-cell scale, the system helps scientists comprehend not only which treatments are successful but also the reasons behind their success or failure based on their interplay within the tumor surrounding.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

What Is the Regional Outlook for the In-Vitro Toxicology Testing Market?

North America was the largest region in the in- vitro toxicology testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the in- vitro toxicology testing market report during the forecast period. The regions covered in the in-vitro toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7987

This Report Delivers Insight On:

1. How big is the in-vitro toxicology testing market, and how is it changing globally?

2. Who are the major companies in the in-vitro toxicology testing market, and how are they performing?

3. What are the key opportunities and risks in the in-vitro toxicology testing market right now?

4. Which products or customer segments are growing the most in the in-vitro toxicology testing market?

5. What factors are helping or slowing down the growth of the in-vitro toxicology testing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model